Demyelinating polyneuropathy and lymphoplasmacytic lymphoma coexisting in 36-year-old man: A case report

Autor Rozłucka, Lesia, Semik-Grabarczyk, Elżbieta, Pietrukaniec, Marta, Żak-Gołąb, Agnieszka, Grabarczyk, Małgorzata, Grosicki, Sebastian, Holecki, Michał
Vydáno v World J Clin Cases (2020)

Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma

Autor Arnulf, Bertrand, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, van de Velde, Helgi, Feng, Huaibao, Cakana, Andrew, Deraedt, William, Moreau, Philippe
Vydáno 2012

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

Autor van Oers, Marinus, Smolej, Lukas, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Davis, Jaclyn, Banerjee, Hiya, Stefanelli, Tommaso, Hoever, Petra, Geisler, Christian
Vydáno v Blood Cancer J (2019)

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Autor Kipps, Thomas J., Eradat, Herbert, Grosicki, Sebastian, Catalano, John, Cosolo, Walter, Dyagil, Iryna S., Yalamanchili, Sreeni, Chai, Akiko, Sahasranaman, Srikumar, Punnoose, Elizabeth, Hurst, Deborah, Pylypenko, Halyna
Vydáno v Leuk Lymphoma (2015)

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study

Autor Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, Rekhtman, Grigoriy, Masliak, Zvenyslava, Robak, Pawel, Esseltine, Dixie-Lee, Feng, Huaibao, Deraedt, William, van de Velde, Helgi, Arnulf, Bertrand
Vydáno v Haematologica (2015)

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

Autor Masternak, Marta, Puła, Bartosz, Knap, Joanna, Waszczuk-Gajda, Anna, Drozd-Sokołowska, Joanna, Wdowiak, Kamil, Grosicki, Sebastian, Kozłowska, Izabela, Kaźmierczak, Marta, Łabędź, Anna, Szukalski, Łukasz, Wiśniewski, Kamil, Subocz, Edyta, Hałka, Janusz, Szymczyk, Agnieszka, Hus, Marek, Jamroziak, Krzysztof, Giannopoulos, Krzysztof
Vydáno v Cancer Manag Res (2020)

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Autor Burger, Jan A., Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Tedeschi, Alessandra, Bairey, Osnat, Hillmen, Peter, Coutre, Steven E., Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Simpson, David, Offner, Fritz, Moreno, Carol, Dai, Sandra, Lal, Indu, Dean, James P., Kipps, Thomas J.
Vydáno v Leukemia (2019)

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

Autor Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Tedeschi, Alessandra, Bairey, Osnat, Bartlett, Nancy L., Burger, Jan A., Hillmen, Peter, Coutre, Steven, Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Li, Jianyong, Simpson, David, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Styles, Lori, James, Danelle, Kipps, Thomas J., Ghia, Paolo
Vydáno v Haematologica (2018)

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

Autor Tausch, Eugen, Beck, Philipp, Schlenk, Richard F., Jebaraj, Billy M.C., Dolnik, Anna, Yosifov, Deyan Y., Hillmen, Peter, Offner, Fritz, Janssens, Ann, Babu, K. Govind, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, McKeown, Astrid, Gupta, Ira V., Skorupa, Alexandra, Pallaud, Celine, Bullinger, Lars, Mertens, Daniel, Döhner, Hartmut, Stilgenbauer, Stephan
Vydáno v Haematologica (2020)

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

Autor San-Miguel, Jesús, Bladé, Joan, Shpilberg, Ofer, Grosicki, Sebastian, Maloisel, Frédéric, Min, Chang-Ki, Polo Zarzuela, Marta, Robak, Tadeusz, Prasad, Sripada V. S. S., Tee Goh, Yeow, Laubach, Jacob, Spencer, Andrew, Mateos, María-Victoria, Palumbo, Antonio, Puchalski, Tom, Reddy, Manjula, Uhlar, Clarissa, Qin, Xiang, van de Velde, Helgi, Xie, Hong, Orlowski, Robert Z.
Vydáno 2014

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth...

Autor Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San‐Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter‐Croneck, Adam, Magen, Hila, Mateos, Maria‐Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Bleickardt, Eric, Poulart, Valerie, Sheng, Jennifer, Sy, Oumar, Katz, Jessica, Singhal, Anil, Richardson, Paul
Vydáno v Br J Haematol (2017)

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

Autor Knop, Stefan, Mateos, Maria-Victoria, Dimopoulos, Meletios A., Suzuki, Kenshi, Jakubowiak, Andrzej, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Usenko, Ganna, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Losava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Wang, Jianping, Wroblewski, Susan, Kudva, Anupa, Gries, Katharine S., Fastenau, John, San-Miguel, Jesus, Cavo, Michele
Vydáno v BMC Cancer (2021)

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies

Autor Robak, Tadeusz, Burger, Jan A., Tedeschi, Alessandra, Barr, Paul M., Owen, Carolyn, Bairey, Osnat, Hillmen, Peter, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, McCarthy, Helen, Coutre, Steven E., Quach, Hang, Gaidano, Gianluca, Maslyak, Zvenyslava, Stevens, Don A., Moreno, Carol, Gill, Devinder S., Flinn, Ian W., Gribben, John G., Mokatrin, Ahmad, Cheng, Mei, Styles, Lori, James, Danelle F., Kipps, Thomas J., Ghia, Paolo
Vydáno v Am J Hematol (2018)

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Autor Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Weisel, Katja, San-Miguel, Jesus, Shpilberg, Ofer, Grosicki, Sebastian, Špička, Ivan, Walter-Croneck, Adam, Magen, Hila, Mateos, Maria-Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z., Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Matsumoto, Morio, Wu, Ka Lung, Anderson, Kenneth C., Jou, Ying-Ming, Ganetsky, Alex, Singhal, Anil K., Richardson, Paul G.
Vydáno v Blood Cancer J (2020)

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Autor Chyra, Zuzana, Sevcikova, Tereza, Vojta, Petr, Puterova, Janka, Brozova, Lucie, Growkova, Katerina, Filipova, Jana, Zatopkova, Martina, Grosicki, Sebastian, Barchnicka, Agnieszka, Wiktor-Jedrzejczak, Wieslaw, Waszczuk-Gajda, Anna, Jungova, Alexandra, Mikulasova, Aneta, Hajduch, Marian, Mokrejs, Martin, Pour, Ludek, Stork, Martin, Harvanova, Lubica, Mistrik, Martin, Mikala, Gabor, Robak, Pawel, Czyz, Anna, Debski, Jakub, Usnarska-Zubkiewicz, Lidia, Jurczyszyn, Artur, Stejskal, Lukas, Morgan, Gareth, Kryukov, Fedor, Budinska, Eva, Simicek, Michal, Jelinek, Tomas, Hrdinka, Matous, Hajek, Roman
Vydáno v Haematologica (2020)

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

Autor Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopińska-Posłuszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi
Vydáno v J Clin Oncol (2021)

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Autor Burger, Jan A., Tedeschi, Alessandra, Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Bartlett, Nancy L., Li, Jianyong, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, McCarthy, Helen, Coutre, Steven, Quach, Hang, Gaidano, Gianluca, Maslyak, Zvenyslava, Stevens, Don A., Janssens, Ann, Offner, Fritz, Mayer, Jiří, O'Dwyer, Michael, Hellmann, Andrzej, Schuh, Anna, Siddiqi, Tanya, Polliack, Aaron, Tam, Constantine S., Suri, Deepali, Cheng, Mei, Clow, Fong, Styles, Lori, James, Danelle F., Kipps, Thomas J.
Vydáno v N Engl J Med (2015)

Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial

Autor Dimopoulos, Meletios, Sanz, Ramon Garcia, Lee, Hui-Peng, Trneny, Marek, Varettoni, Marzia, Opat, Stephen, D'Sa, Shirley, Owen, Roger G., Cull, Gavin, Mulligan, Stephen, Czyz, Jaroslaw, Castillo, Jorge J., Motta, Marina, Siddiqi, Tanya, Gironella Mesa, Mercedes, Granell Gorrochategui, Miquel, Talaulikar, Dipti, Zinzani, Pier Luigi, Askari, Elham, Grosicki, Sebastian, Oriol, Albert, Rule, Simon, Kloczko, Janusz, Tedeschi, Alessandra, Buske, Christian, Leblond, Veronique, Trotman, Judith, Chan, Wai Y., Michel, Jan, Schneider, Jingjing, Tan, Ziwen, Cohen, Aileen, Huang, Jane, Tam, Constantine S.
Vydáno v Blood Adv (2020)

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study...

Autor Thieblemont, Catherine, Howlett, Susannah, Casasnovas, René‐Olivier, Mounier, Nicolas, Perrot, Aurore, Morschhauser, Franck, Fruchart, Christophe, Daguindau, Nicolas, van Eygen, Koen, Obéric, Lucie, Bouabdallah, Reda, Pica, Gian Matteo, Nicolas‐Virezelier, Emmanuelle, Abraham, Julie, Fitoussi, Olivier, Snauwaert, Sylvia, Eisenmann, Jean‐Claude, Lionne‐Huyghe, Pauline, Bron, Dominique, Tricot, Sabine, Deeren, Dries, Gonzalez, Hugo, Costello, Régis, Le Du, Katell, da Silva, Maria Gomes, Grosicki, Sebastian, Trotman, Judith, Catalano, John, Caballero, Dolores, Greil, Richard, Cohen, Amos M., Gaulard, Philippe, Roulin, Louise, Takeshita, Kenichi, Casadebaig, Marie‐Laure, Tilly, Hervé, Coiffier, Bertrand
Vydáno v Br J Haematol (2019)

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

Autor Mateos, Maria V., Gavriatopoulou, Maria, Facon, Thierry, Auner, Holger W., Leleu, Xavier, Hájek, Roman, Dimopoulos, Meletios A., Delimpasi, Sosana, Simonova, Maryana, Špička, Ivan, Pour, Ludĕk, Kriachok, Iryna, Pylypenko, Halyna, Doronin, Vadim, Usenko, Ganna, Benjamin, Reuben, Dolai, Tuphan K., Sinha, Dinesh K., Venner, Christopher P., Garg, Mamta, Stevens, Don A., Quach, Hang, Jagannath, Sundar, Moreau, Philippe, Levy, Moshe, Badros, Ashraf Z., Anderson, Larry D., Bahlis, Nizar J., Cavo, Michele, Chai, Yi, Jeha, Jacqueline, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Richardson, Paul G., Grosicki, Sebastian
Vydáno v J Hematol Oncol (2021)